Previous 10 | Next 10 |
2023-11-03 14:08:27 ET DENVER, Colo., Nov 3, 2023 ( www.247marketnews.com )- The following companies were among the listings that we covered this week; Verve Therapeutics Inc (NASDAQ: VERV), Cellectis (NASDAQ: CLLS), Palantir Technologies (NYSE: PLTR), Werewolf Therapeutics (N...
2023-11-01 05:40:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cathie Wood, the brilliant mind behind ARK Invest , is known for her unique ability to spot disruptive trends in stocks. Her investment strategies have made waves in the financial world, an...
2023-10-31 19:09:02 ET A multimillion-dollar deal in the healthcare industry announced on Tuesday led to share price pops for two of the three parties involved. Shares of Beam Therapeutics (NASDAQ: BEAM) and Verve Therapeutics (NASDAQ: VERV) shot up 11% and 28%, respectively...
2023-10-31 17:24:37 ET Gainers: Freshworks (FRSH) +5% . Verve Therapeutics ( VERV ) +3% . Expensify ( EXFY ) +3% . REGENXBIO ( RGNX ) +3% . ACI Worldwide ( ACIW ) +3% . Losers: Big 5 Sporting Goods ( BGFV ) -11% . ...
2023-10-31 12:46:31 ET More on Eli Lilly Albemarle Vs. Eli Lilly: 1 Potentially Set To Soar And 1 Bubble Stock To Ignore Eli Lilly: The GLP-1 Opportunity, While Increasingly Recognized, Is Vastly Underestimated Eli Lilly: Do Not Chase This Stock Over The Cliff ...
2023-10-31 10:04:17 ET DENVER, Colo., Oct. 31, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Cardio Diagnostics Holdings Inc (NASDAQ: CDIO), X4 Pharmaceuticals Inc (NASDAQ: XFOR), SciSparc Ltd (NASDAQ: ...
2023-10-31 10:00:02 ET More on Health Care Select Sector SPDR Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further details see: Sarepta Therapeutics, Petmed Express among healthcare movers
2023-10-31 06:38:32 ET More on Beam, Eli Lilly, etc. Albemarle Vs. Eli Lilly: 1 Potentially Set To Soar And 1 Bubble Stock To Ignore Beam: Opportunity Based On SCD Data Readout In 2024 Eli Lilly: The GLP-1 Opportunity, While Increasingly Recognized, Is Vastly Underes...
BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc. , a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the expansion of its relationship with Eli Lilly and Comp...
2023-10-30 08:30:00 ET On October 23, regulators at the Food and Drug Administration (FDA) cleared a key obstacle for Verve Therapeutics (NASDAQ: VERV) , giving it the green light to proceed with an early-stage clinical trial in the U.S. to investigate one of its gene-editing therap...
News, Short Squeeze, Breakout and More Instantly...
Verve Therapeutics Inc. Company Name:
VERV Stock Symbol:
NASDAQ Market:
Verve Therapeutics Inc. Website:
2024-07-08 07:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics , a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its boar...
2024-06-15 11:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...